Sign In
Buy AVNS
$24.98
-0.0150 (-0.0600%)
At Close: Jun 03, 2026
BRKR's Canopy Biosciences Partners With Enable Medicine
09:08am, Thursday, 13'th Apr 2023
BRKR's Canopy Biosciences collaborates with Enable Medicine to bring advanced spatial analysis pipelines to the Canopy CellScape System for high-plex spatial biology.
Is Avanos Medical (AVNS) Outperforming Other Medical Stocks This Year?
11:29am, Friday, 07'th Apr 2023
Here is how Avanos Medical (AVNS) and Becton Dickinson (BDX) have performed compared to their sector so far this year.
3 Reasons to Add Avanos (AVNS) Stock to Your Portfolio
01:42pm, Thursday, 06'th Apr 2023
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Avanos Medical, Inc. to Present at the 2023 Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
07:42am, Wednesday, 15'th Mar 2023
ALPHARETTA, Ga. , March 15, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer and chief transformation office
Should Value Investors Buy Avanos Medical (AVNS) Stock?
11:17am, Thursday, 02'nd Mar 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
What Makes Avanos Medical (AVNS) a New Buy Stock
01:33pm, Friday, 24'th Feb 2023
Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Avanos (AVNS) Q4 Earnings Surpass Estimates, Margins Up
09:47am, Wednesday, 22'nd Feb 2023
Avanos' (AVNS) fourth-quarter 2022 results reflect strength in both segments.
Avanos Medical (AVNS) Q4 Earnings and Revenues Beat Estimates
12:04am, Wednesday, 22'nd Feb 2023
Avanos Medical (AVNS) delivered earnings and revenue surprises of 25% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. (AVNS) Q4 2022 Earnings Call Transcript
12:30pm, Tuesday, 21'st Feb 2023
Avanos Medical, Inc. (NYSE:AVNS ) Q4 2022 Earnings Conference Call February 21, 2023 9:00 AM ET Company Participants Scott Galovan - Senior Vice President, Strategy and M&A Joe Woody - Chief Executive
Avanos Medical (AVNS) Q4 Earnings and Revenues Beat Estimates
10:32am, Tuesday, 21'st Feb 2023
Avanos Medical (AVNS) delivered earnings and revenue surprises of 25% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2022 Financial Results
05:49am, Tuesday, 14'th Feb 2023
ALPHARETTA, Ga. , Feb. 14, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full
Avanos Medical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
02:36pm, Wednesday, 04'th Jan 2023
ALPHARETTA, Ga. , Jan. 4, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the 41st Annual J.P.
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2023
09:47am, Friday, 09'th Dec 2022
Here are some dirt-cheap MedTech value stocks - DYNT, INGN, AVNS - which are expected to provide long-term gains.
3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
12:03pm, Thursday, 08'th Dec 2022
Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.
Avanos: TriVisc Offering Appealing, Strong Growth Across Rest Of Product Portfolio, Revise To Buy
01:45am, Tuesday, 06'th Dec 2022
Revenue for the third quarter 2022 was $202mm, up 9.8% compared to last year. Substantial uplift in operating income, fetching $27mm, representing YoY growth of ~59%.
